Other · developed by Viatris Innovation GmbH
AC-076 is a lyophilized injectable formulation, reconstituted with water for injection before use.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT03173625 | Phase 1 | Healthy Subjects | Completed | VTRS |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Healthy Subjects
Updated Nov 1, 2026. Something wrong or missing? Report it on the VTRS page.
See VTRS's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
VTRS catalysts and pipeline →